Clinical trials: HIV-2
Acquired Immunodeficiency Syndrome, Blood Donors
Retrovirus Epidemiology Donor Study I (REDS I)
To conduct a multicenter epidemiologic study of the human retroviruses HIV-1, HIV-2, HTLV-I, and HTLV-II in volunteer blood donors from areas of the United States that were reportedly at high and medium or low risk for HIV.
- Conditions
- Acquired Immunodeficiency Syndrome, Blood Donors, Blood Transfusion, HIV Infections
- Trial name
- NCT00005278
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
HIV Antibody Testing
Use of OraQuick for Screening HIV in Children Less Than Eighteen Months Old
Blood is the most commonly used specimen to test for HIV. In the past 20 years, use of saliva as an alternative specimen for HIV testing has been explored.
- Trial name
- NCT00378118
- Testing
- Abbott-rapid HIV antibody test, OraQuick Rapid HIV-1/2 Antibody test
- Where
- Zambia
- Volunteers
- 1,000 people
- Sponsor
- Thrasher Research Fund
Acquired Immunodeficiency Syndrome, Blood Donors
Retrovirus Epidemiology Donor Study-II (REDS-II)
To conduct epidemiological, laboratory, and survey research on volunteer blood donors within the United States to ensure the safety and availability of the United States' blood supply.
- Conditions
- Acquired Immunodeficiency Syndrome, Blood Donors, Blood Transfusion, HIV Infections
- Trial name
- NCT00097006
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)